Logo

GSK buys liver disease drug for up to $2 bn

GSK buys liver disease drug for up to $2 bn

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a common form of liver disease, in a deal worth up to $2 billion.

👉 Full Story